John Tipton - Verano Holdings President
| VRNOF Stock | USD 1.70 0.06 3.66% |
Insider
John Tipton is President of Verano Holdings Corp
| Age | 62 |
| Phone | 312 265 0730 |
| Web | https://www.verano.com |
Verano Holdings Management Efficiency
The company has return on total asset (ROA) of 0.0291 % which means that it generated a profit of $0.0291 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0103) %, meaning that it generated substantial loss on money invested by shareholders. Verano Holdings' management efficiency ratios could be used to measure how well Verano Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mark Baldyga | Biofrontera | N/A | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
| Jeff Holm | Biofrontera | N/A | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| BComm BCom | Akanda Corp | 68 | |
| Thomas Flow | Akanda Corp | 46 | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| John Weston | cbdMD Inc | N/A | |
| Amos Cohen | INC Research Holdings | 45 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Tejinder Virk | Akanda Corp | 42 | |
| Raymond Coffman | cbdMD Inc | 62 | |
| Kevin MacDermott | cbdMD Inc | 62 | |
| Eugene III | Biofrontera | 39 | |
| Advocate Ohayon | INC Research Holdings | 35 | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Hermann Lubbert | Biofrontera | 68 | |
| Erica CPA | Biofrontera | 39 | |
| Sandra Beaver | Evolus Inc | 46 | |
| David Erickson | Evolus Inc | N/A | |
Management Performance
| Return On Equity | -0.0103 | |||
| Return On Asset | 0.0291 |
Verano Holdings Corp Leadership Team
Elected by the shareholders, the Verano Holdings' board of directors comprises two types of representatives: Verano Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Verano. The board's role is to monitor Verano Holdings' management team and ensure that shareholders' interests are well served. Verano Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Verano Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Tipton, President | ||
| Julianna CFA, Director Relations | ||
| David Spreckman, Ex Marketing | ||
| Aaron Miles, Chief Officer | ||
| Samuel Dorf, CoFounder Officer | ||
| George Archos, Chairman Founder | ||
| Darren Esq, Chief COO | ||
| Brett Summerer, Chief Officer | ||
| Destiny Thompson, Chief Officer |
Verano Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is Verano Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0103 | |||
| Return On Asset | 0.0291 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 1.53 B | |||
| Shares Outstanding | 324.32 M | |||
| Shares Owned By Insiders | 18.86 % | |||
| Shares Owned By Institutions | 3.00 % | |||
| Price To Earning | 9.56 X | |||
| Price To Book | 0.74 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Verano OTC Stock
Verano Holdings financial ratios help investors to determine whether Verano OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Verano with respect to the benefits of owning Verano Holdings security.